ATE476447T1 - Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität - Google Patents
Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivitätInfo
- Publication number
- ATE476447T1 ATE476447T1 AT03739341T AT03739341T ATE476447T1 AT E476447 T1 ATE476447 T1 AT E476447T1 AT 03739341 T AT03739341 T AT 03739341T AT 03739341 T AT03739341 T AT 03739341T AT E476447 T1 ATE476447 T1 AT E476447T1
- Authority
- AT
- Austria
- Prior art keywords
- wisp
- modulating
- compositions
- methods
- activity
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 101710137353 CCN family member 4 Proteins 0.000 abstract 5
- 102100031173 CCN family member 4 Human genes 0.000 abstract 5
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 102100032912 CD44 antigen Human genes 0.000 abstract 1
- 101000777560 Homo sapiens CCN family member 4 Proteins 0.000 abstract 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39265202P | 2002-06-29 | 2002-06-29 | |
| US40873902P | 2002-09-06 | 2002-09-06 | |
| PCT/US2003/020407 WO2004003158A2 (en) | 2002-06-29 | 2003-06-28 | Methods and compositions for modulating and detecting wisp activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE476447T1 true ATE476447T1 (de) | 2010-08-15 |
Family
ID=30003268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03739341T ATE476447T1 (de) | 2002-06-29 | 2003-06-28 | Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7456262B2 (de) |
| EP (1) | EP1572931B1 (de) |
| JP (1) | JP4636497B2 (de) |
| AT (1) | ATE476447T1 (de) |
| AU (1) | AU2003245733B2 (de) |
| CA (1) | CA2489515C (de) |
| DE (1) | DE60333669D1 (de) |
| DK (1) | DK1572931T3 (de) |
| IL (1) | IL165776A (de) |
| WO (1) | WO2004003158A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7455834B2 (en) * | 2002-06-29 | 2008-11-25 | Genentech, Inc. | Methods and compositions for modulating and detecting WISP activity |
| DK1572931T3 (da) | 2002-06-29 | 2010-11-08 | Genentech Inc | Fremgangsmåder og sammensætninger til modulering og påvisning af WISP-aktivitet |
| JP2007505131A (ja) * | 2003-09-11 | 2007-03-08 | ジェネンテック・インコーポレーテッド | Ｗｉｓｐアンタゴニストの使用方法 |
| US8460658B2 (en) | 2003-10-10 | 2013-06-11 | Alchemia Oncology Pty Limited | Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |
| NZ546272A (en) * | 2003-10-10 | 2009-05-31 | Alchemia Oncology Pty Ltd | The modulation of hyaluronan synthesis and degradation in the treatment of disease |
| JP5048323B2 (ja) * | 2004-03-31 | 2012-10-17 | 株式会社ツーセル | 損傷組織の治療剤と治療方法 |
| CN113087772B (zh) * | 2021-04-27 | 2022-04-22 | 清华大学深圳国际研究生院 | 一种rhamm拮抗多肽及其衍生物与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE406441T1 (de) | 1997-10-29 | 2008-09-15 | Genentech Inc | Verwendung des wnt-1 induzierten sekretierten polypeptids wisp-1 |
| ES2321954T3 (es) | 1999-03-08 | 2009-06-15 | Genentech, Inc. | Composiciones y procedimientos para el diagnostico de tumores. |
| DK1572931T3 (da) | 2002-06-29 | 2010-11-08 | Genentech Inc | Fremgangsmåder og sammensætninger til modulering og påvisning af WISP-aktivitet |
| JP2007505131A (ja) | 2003-09-11 | 2007-03-08 | ジェネンテック・インコーポレーテッド | Ｗｉｓｐアンタゴニストの使用方法 |
-
2003
- 2003-06-28 DK DK03739341.0T patent/DK1572931T3/da active
- 2003-06-28 WO PCT/US2003/020407 patent/WO2004003158A2/en active Search and Examination
- 2003-06-28 DE DE60333669T patent/DE60333669D1/de not_active Expired - Lifetime
- 2003-06-28 AU AU2003245733A patent/AU2003245733B2/en not_active Ceased
- 2003-06-28 JP JP2004549836A patent/JP4636497B2/ja not_active Expired - Lifetime
- 2003-06-28 CA CA2489515A patent/CA2489515C/en not_active Expired - Fee Related
- 2003-06-28 AT AT03739341T patent/ATE476447T1/de active
- 2003-06-28 EP EP03739341A patent/EP1572931B1/de not_active Expired - Lifetime
- 2003-06-28 US US10/519,621 patent/US7456262B2/en not_active Expired - Lifetime
-
2004
- 2004-12-15 IL IL165776A patent/IL165776A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US7456262B2 (en) | 2008-11-25 |
| EP1572931A2 (de) | 2005-09-14 |
| AU2003245733B2 (en) | 2009-11-26 |
| EP1572931B1 (de) | 2010-08-04 |
| IL165776A (en) | 2010-06-30 |
| DK1572931T3 (da) | 2010-11-08 |
| IL165776A0 (en) | 2006-01-15 |
| JP4636497B2 (ja) | 2011-02-23 |
| WO2004003158A2 (en) | 2004-01-08 |
| US20060073135A1 (en) | 2006-04-06 |
| WO2004003158A3 (en) | 2005-08-04 |
| EP1572931A4 (de) | 2006-03-01 |
| CA2489515A1 (en) | 2004-01-08 |
| JP2006516956A (ja) | 2006-07-13 |
| DE60333669D1 (de) | 2010-09-16 |
| CA2489515C (en) | 2013-01-22 |
| AU2003245733A1 (en) | 2004-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE542920T1 (de) | Modifiziertes menschliches wachstumshormon | |
| ATE359515T1 (de) | Proteinmarker für lungenkrebs und deren verwendung | |
| CY1111097T1 (el) | Πρωτεϊνη δεσμευσης του υποδοχεα nogo | |
| BRPI0315666B8 (pt) | dna de a34 e a33 do tipo 3, proteínas, seus anticorpos e métodos de tratamento usando os mesmos | |
| ATE255420T1 (de) | Verwendung von tumorzellen zeitversetzt in kombination mit intakten antikörpern zur immunisierung | |
| DE69942753D1 (de) | Peptidantagonist von Zonulin und dessen Verwendung | |
| NO960767L (no) | Protocadherinproteiner og deres anvendelse | |
| DK1887014T3 (da) | Humane Toll-homologer | |
| DE502005009389D1 (de) | Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern | |
| WO2005087811A3 (en) | Estrogen receptors and methods of use | |
| DE60310385D1 (de) | Sekretion von proteinen mit mehreren disulfidbindungen in bakterien und verwendungen davon | |
| PT686161E (pt) | Novas sub-unidades humanas de alfa integrina 2 | |
| ATE391136T1 (de) | Fas peptide und antikörper zur modulierung von apoptosis | |
| ATE476447T1 (de) | Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität | |
| ATE462727T1 (de) | An menschliches roundabout bindende antikörper, polypeptide und ihre verwendung zur hemmung der angiogenese | |
| ATE360695T1 (de) | Cortistatin: neuropeptide, zusammensetzungen und methoden | |
| NO20075825L (no) | Fremgangsmater og preparater til modulering og pavisning av WISP-aktivitet | |
| DE69115917D1 (de) | Humane gammainterferonantagonisten | |
| DE3684578D1 (de) | Monoklonale antikoerper mit bindungsspezifitaet fuer menschliche prostatatumorantigene und methoden fuer ihre verwendung. | |
| ATE306668T1 (de) | Diagnose von brustkrebs unter verwendung von bcmp-7 als marker | |
| ATE532796T1 (de) | Immunassays zur spezifischen bestimmung von scca- isoformen | |
| AU2003302901A8 (en) | Human recombinant endooligopeptidase a (heopa) | |
| HUP0200285A2 (hu) | Glükóz-dehidrogenáz fúziós fehérjék és alkalmazásuk expressziós rendszerekben | |
| ATE508366T1 (de) | Polypeptidmarker zur diagnose von arteriosklerose | |
| ATE542900T1 (de) | Icbp90-polypeptide, polypeptidfragmente davon, die dafür kodierenden polynukleotide, und ihre verwendung zur behandlung und diagnose von krebs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1572931 Country of ref document: EP |